Aurinia Pharmaceuticals (AUPH) Earnings (2020 - 2026)
Aurinia Pharmaceuticals (AUPH) earnings from Mar 31, 2020 to Mar 31, 2026. The TTM Aurinia Pharmaceuticals (AUPH) earnings is $222M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Aurinia Pharmaceuticals (AUPH) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +524.44% |
Annual Earnings change of Aurinia Pharmaceuticals (AUPH)
| Year | Earnings | Change |
|---|---|---|
| 2026 | $34M | -83.70% |
| 2025 | $211M | +14640.56% |
| 2024 | $1.43M | -105.32% |
| 2023 | -$27M | +3.15% |
| 2022 | -$26M | -21.82% |
| 2021 | -$33M | -67.55% |
| 2020 | -$103M | +16.18% |
| 2019 | -$88M | +66.50% |
| 2018 | -$53M | -25.02% |
| 2017 | -$71M | +203.95% |
| 2016 | -$23M | N/A |